(Q52948414)

9 May 2018

reason for preferred rank

title

Isolated Limb Perfusion with rhTNF-?? and Melphalan for Locally Recurrent Childhood Synovial Sarcoma of the Limb (English)

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

30 March 2024

Isolated limb perfusion with rhTNF-alpha and melphalan for locally recurrent childhood synovial sarcoma of the limb (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14608203

30 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

30 March 2024

author name string

Peter Hohenberger

1

1 reference

9 May 2018

Per Ulf Tunn

2

1 reference

9 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14608203

30 March 2024

publication date

1 November 2003

1 reference

9 May 2018

full work available at URL

https://journals.lww.com/00043426-200311000-00016

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Journal of Pediatric Hematology/Oncology

30 March 2024

published in

1 reference

9 May 2018

volume

25

1 reference

9 May 2018

issue

11

1 reference

9 May 2018

page(s)

905-909

1 reference

9 May 2018

A novel fusion gene, SYT-SSX4, in synovial sarcoma.

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Synovial sarcoma in children and adolescents. A report from the Kiel Pediatric Tumor Registry

30 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86

30 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome

30 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit

30 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan

30 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Development of a measure of physical function for patients with bone and soft tissue sarcoma.

30 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment

30 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Synovial sarcoma: identification of low and high risk groups

30 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.

30 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Synovial sarcoma: report of a series of 25 consecutive children from a single institution

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

THE ROLE OF CHEMOTHERAPY IN CHILDHOOD SOFT TISSUE SARCOMAS OTHER THAN RHABDOMYOSARCOMAS: Experience of the Northern Israel Oncology Center

30 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors

30 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma

30 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Second malignant neoplasms in children after treatment of soft tissue sarcoma

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Brachytherapy for pediatric soft-tissue sarcoma

30 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

Innovation in the management of soft tissue sarcomas in infants and young children: high-dose-rate brachytherapy

30 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00043426-200311000-00016

30 March 2024

Identifiers

1 reference

9 May 2018

1 reference

9 May 2018